0229 GMT - IHH Healthcare's long-term prospects still look positive, RHB IB analyst Oong Chun Sung writes in a research report as he raises the stock's target price to MYR8.00 from MYR7.90. If the healthcare provider hits its bed expansion target of 4,000 beds by 2028, it can tap into regions where quality healthcare is scarce, Oong says. RHB IB also likes IHH's reputable footprint across key markets and focus on affluent clients, which offer earnings resiliency. RHB IB maintains a buy rating on the stock, which is up 0.2% at MYR6.30.(amanda.lee@wsj.com)
(END) Dow Jones Newswires
August 29, 2024 22:40 ET (02:40 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments